Fibulin-2 is present in murine vascular lesions and is important for smooth muscle cell migration.

PubWeight™: 1.09‹?› | Rank: Top 10%

🔗 View Article (PMID 16409997)

Published in Cardiovasc Res on January 10, 2006

Authors

Asa Ström1, Anders I Olin, Anders Aspberg, Anna Hultgårdh-Nilsson

Author Affiliations

1: Department of Experimental Medical Science, Division of Vascular and Airway Research, Lund University, BMC, C12, S-221 84 Lund, Sweden. asa.strom@med.lu.se

Articles citing this

Kidney failure in mice lacking the tetraspanin CD151. J Cell Biol (2006) 1.85

Cell proliferation and interleukin-6-type cytokine signaling are implicated by gene expression responses in early optic nerve head injury in rat glaucoma. Invest Ophthalmol Vis Sci (2011) 1.35

Loss of fibulin-2 expression is associated with breast cancer progression. Am J Pathol (2007) 1.17

Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling. J Am Heart Assoc (2013) 1.08

Vascular wall extracellular matrix proteins and vascular diseases. Biochim Biophys Acta (2014) 0.99

The redox state of transglutaminase 2 controls arterial remodeling. PLoS One (2011) 0.97

The portal fibroblast: not just a poor man's stellate cell. Gastroenterology (2014) 0.93

Fibulin-2 and fibulin-5 cooperatively function to form the internal elastic lamina and protect from vascular injury. Arterioscler Thromb Vasc Biol (2009) 0.93

Neutrophil elastase is produced by pulmonary artery smooth muscle cells and is linked to neointimal lesions. Am J Pathol (2011) 0.91

Identification of differentially regulated secretome components during skeletal myogenesis. Mol Cell Proteomics (2011) 0.90

Expression of ECM proteins fibulin-1 and -2 in acute and chronic liver disease and in cultured rat liver cells. Cell Tissue Res (2009) 0.89

Two variants in the fibulin2 gene are associated with lower systolic blood pressure and decreased risk of hypertension. PLoS One (2012) 0.88

Fibulin-2 deficiency attenuates angiotensin II-induced cardiac hypertrophy by reducing transforming growth factor-β signalling. Clin Sci (Lond) (2014) 0.87

Loss of fibulin-2 protects against progressive ventricular dysfunction after myocardial infarction. J Mol Cell Cardiol (2011) 0.86

Secreted proteins from carotid endarterectomy: an untargeted approach to disclose molecular clues of plaque progression. J Transl Med (2013) 0.85

Fibulin 2, a tyrosine O-sulfated protein, is up-regulated following retinal detachment. J Biol Chem (2014) 0.80

Effects of estradiol on transcriptional profiles in atherosclerotic iliac arteries in ovariectomized cynomolgus macaques. Menopause (2014) 0.77

Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway Inhibition. PLoS One (2015) 0.77

Fibulin-3 may improve vascular health through inhibition of MMP-2/9 and oxidative stress in spontaneously hypertensive rats. Mol Med Rep (2016) 0.75

Evaluation of Left Ventricle Function by Regional Fractional Area Change (RFAC) in a Mouse Model of Myocardial Infarction Secondary to Valsartan Treatment. PLoS One (2015) 0.75

Articles by these authors

Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense. Blood (2011) 1.87

P2 receptor expression profiles in human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol (2002) 1.55

Versican interacts with fibrillin-1 and links extracellular microfibrils to other connective tissue networks. J Biol Chem (2001) 1.41

C1q inhibits immune complex-induced interferon-alpha production in plasmacytoid dendritic cells: a novel link between C1q deficiency and systemic lupus erythematosus pathogenesis. Arthritis Rheum (2009) 1.37

Human IgG/Fc gamma R interactions are modulated by streptococcal IgG glycan hydrolysis. PLoS One (2008) 1.37

Tissue fibrocytes in patients with mild asthma: a possible link to thickness of reticular basement membrane? Respir Res (2006) 1.25

Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis. Arthritis Rheum (2010) 1.23

A missense mutation in the aggrecan C-type lectin domain disrupts extracellular matrix interactions and causes dominant familial osteochondritis dissecans. Am J Hum Genet (2010) 1.22

Alternative splicing in the aggrecan G3 domain influences binding interactions with tenascin-C and other extracellular matrix proteins. J Biol Chem (2004) 1.15

The decorin sequence SYIRIADTNIT binds collagen type I. J Biol Chem (2007) 1.15

Structural basis for interactions between tenascins and lectican C-type lectin domains: evidence for a crosslinking role for tenascins. Structure (2004) 1.14

A constitutive endogenous osteopontin production is important for macrophage function and differentiation. Exp Cell Res (2007) 1.13

Asporin competes with decorin for collagen binding, binds calcium and promotes osteoblast collagen mineralization. Biochem J (2009) 1.09

The CXC chemokine MIG/CXCL9 is important in innate immunity against Streptococcus pyogenes. J Infect Dis (2007) 1.08

Nuclear factor of activated T cells regulates osteopontin expression in arterial smooth muscle in response to diabetes-induced hyperglycemia. Arterioscler Thromb Vasc Biol (2009) 1.08

The leucine-rich repeat protein PRELP binds perlecan and collagens and may function as a basement membrane anchor. J Biol Chem (2002) 1.08

The major basement membrane components localize to the chondrocyte pericellular matrix--a cartilage basement membrane equivalent? Matrix Biol (2007) 1.06

Chondroitin sulfate perlecan enhances collagen fibril formation. Implications for perlecan chondrodysplasias. J Biol Chem (2006) 1.06

The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids. Int J Colorectal Dis (2007) 1.04

A novel C3 mutation causing increased formation of the C3 convertase in familial atypical hemolytic uremic syndrome. J Immunol (2012) 0.99

Antibodies against a surface protein of Streptococcus pyogenes promote a pathological inflammatory response. PLoS Pathog (2008) 0.98

Peptidylarginine deiminases present in the airways during tobacco smoking and inflammation can citrullinate the host defense peptide LL-37, resulting in altered activities. Am J Respir Cell Mol Biol (2011) 0.98

Activation of TAFI on the surface of Streptococcus pyogenes evokes inflammatory reactions by modulating the kallikrein/kinin system. J Innate Immun (2008) 0.93

Treatment of invasive streptococcal infection with a peptide derived from human high-molecular weight kininogen. Blood (2009) 0.93

The antibacterial activity of peptides derived from human beta-2 glycoprotein I is inhibited by protein H and M1 protein from Streptococcus pyogenes. Mol Microbiol (2007) 0.93

Midkine and pleiotrophin have bactericidal properties: preserved antibacterial activity in a family of heparin-binding growth factors during evolution. J Biol Chem (2010) 0.92

IgG glycan hydrolysis by endoglycosidase S diminishes the proinflammatory properties of immune complexes from patients with systemic lupus erythematosus: a possible new treatment? Arthritis Rheum (2012) 0.92

Altered vascular remodeling in osteopontin-deficient atherosclerotic mice. J Vasc Res (2004) 0.92

The vascular repair process after injury of the carotid artery is regulated by IL-1RI and MyD88 signalling. Cardiovasc Res (2011) 0.92

SpeB of Streptococcus pyogenes differentially modulates antibacterial and receptor activating properties of human chemokines. PLoS One (2009) 0.92

Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes. J Immunol (2011) 0.91

Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation. Cell Microbiol (2007) 0.90

Thymic stromal lymphopoietin exerts antimicrobial activities. Exp Dermatol (2011) 0.88

Identification of a novel protein promoting the colonization and survival of Finegoldia magna, a bacterial commensal and opportunistic pathogen. Mol Microbiol (2008) 0.87

Inhibition of injury-induced arterial remodelling and carotid atherosclerosis by recombinant human antibodies against aldehyde-modified apoB-100. Atherosclerosis (2006) 0.87

Cartilage oligomeric matrix protein specific antibodies are pathogenic. Arthritis Res Ther (2012) 0.86

The membrane bound LRR lipoprotein Slr, and the cell wall-anchored M1 protein from Streptococcus pyogenes both interact with type I collagen. PLoS One (2011) 0.85

Thylakoids suppress appetite by increasing cholecystokinin resulting in lower food intake and body weight in high-fat fed mice. Phytother Res (2009) 0.84

Human Siglec-5 inhibitory receptor and immunoglobulin A (IgA) have separate binding sites in streptococcal beta protein. J Biol Chem (2011) 0.84

Involvement of the CD1d-natural killer T cell pathway in neointima formation after vascular injury. Circ Res (2007) 0.84

Laminin isoforms in atherosclerotic arteries from mice and man. Histol Histopathol (2011) 0.84

Fibromodulin deficiency reduces low-density lipoprotein accumulation in atherosclerotic plaques in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol (2012) 0.83

SufA of the opportunistic pathogen finegoldia magna modulates actions of the antibacterial chemokine MIG/CXCL9, promoting bacterial survival during epithelial inflammation. J Biol Chem (2009) 0.83

Binding of albumin promotes bacterial survival at the epithelial surface. J Biol Chem (2010) 0.83

A novel mutation in the complement regulator clusterin in recurrent hemolytic uremic syndrome. Mol Immunol (2009) 0.82

Cartilage oligomeric matrix protein deficiency promotes early onset and the chronic development of collagen-induced arthritis. Arthritis Res Ther (2008) 0.82

Collagen and related extracellular matrix proteins in atherosclerotic plaque development. Curr Opin Lipidol (2014) 0.81

Identification of molecular mechanisms used by Finegoldia magna to penetrate and colonize human skin. Mol Microbiol (2014) 0.81

Osteopontin deficiency dampens the pro-atherogenic effect of uraemia. Cardiovasc Res (2013) 0.81

C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis. Autoimmunity (2013) 0.80

Integrin β1, Osmosensing, and Chemoresistance in Mouse Ehrlich Carcinoma Cells. Cell Physiol Biochem (2015) 0.79

Treatment with p33 curtails morbidity and mortality in a histone-induced murine shock model. J Innate Immun (2014) 0.79

A novel role for pro-coagulant microvesicles in the early host defense against streptococcus pyogenes. PLoS Pathog (2013) 0.78

Mobilization of regulatory T cells in response to carotid injury does not influence subsequent neointima formation. PLoS One (2012) 0.78

High expression of midkine in the airways of patients with cystic fibrosis. Am J Respir Cell Mol Biol (2013) 0.78

Expression of MIG/CXCL9 in cystic fibrosis and modulation of its activities by elastase of Pseudomonas aeruginosa. J Innate Immun (2014) 0.77

Increased neointimal thickening in dystrophin-deficient mdx mice. PLoS One (2012) 0.77

The C-type lectin of the aggrecan G3 domain activates complement. PLoS One (2013) 0.77

LPS interactions with immobilized and soluble antimicrobial peptides. Scand J Clin Lab Invest (2010) 0.77

Streptococcal surface proteins activate the contact system and control its antibacterial activity. J Biol Chem (2012) 0.76

p33 (gC1q receptor) prevents cell damage by blocking the cytolytic activity of antimicrobial peptides. J Immunol (2013) 0.76

Characterization of released polypeptides during an interferon-γ-dependent antibacterial response in airway epithelial cells. J Interferon Cytokine Res (2012) 0.75

[Do not treat interns-researchers unfairly!]. Lakartidningen (2003) 0.75

β-Sarcoglycan Deficiency Reduces Atherosclerotic Plaque Development in ApoE-Null Mice. J Vasc Res (2017) 0.75